Latest News
When Yale School of Medicine's Sherry Mansour, MD, first began her training at Yale, she was struck by the high rates of heart failure among her patients with kidney disease. Mansour set out to better understand the biological link between kidney injury and heart failure, aiming to identify patients at the highest risk and ensure they receive timely preventive measures, primary care follow-up, and specialist referrals.
- August 13, 2025Source: WTNH
Yale School of Medicine's F. Perry Wilson, MD, discusses early-onset colorectal cancer, how women's ovulation impacts the moods of others, and a rare condition surging due to the legalization of marijuana.
- July 23, 2025
Meet Melissa Shaw, research associate in Yale School of Medicine's Clinical and Translation Research Accelerator, who plays a key role in the development, implementation, and oversight of various research studies.
- July 14, 2025
The 2025 Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award of The Department of Internal Medicine was presented to two recipients: Benjamin Y. Lu, MD, PhD, of Medical Oncology and Hematology, and Abinet M. Aklilu, MD, MPH, of Nephrology on June 26, 2025.
- June 09, 2025
Yale School of Medicine researchers have identified a biomarker panel that improves the assessment of chronic kidney disease (CKD) progression in children. Their findings were published in the Journal of the American Society of Nephrology.
- May 20, 2025Source: Yale Medicine
The Novavax vaccine is one of three vaccines that are FDA-approved in the United States for the prevention of COVID-19. Yale Medicine answers commonly asked questions about the shot.
- April 30, 2025Source: WTNH
Yale School of Medicine's F. Perry Wilson comments on how virtual reality could be used to diagnose ADHD.
- April 24, 2025
In a new Yale-led study, researchers used a type of AI technology called deep neural network (DNN) analysis to decipher skin involvement and treatment response in patients with systemic sclerosis.
- April 09, 2025
A new Yale study points to type 1 interferons as a potential biomarker for scleroderma patients with a worse prognosis.
- February 28, 2025
A team of Yale researchers demonstrated the effectiveness of a large language model (LLM)-based pipeline in identifying overt gastrointestinal bleeding in 1,108 patients seen between 2014 and 2023 in Yale New Haven Health. The study showed a high accuracy of the model in detecting melena, hematochezia, and hematemesis, identifying recurrent bleeding, and catching more than 98% of cases. The algorithm also increased the average per-patient reimbursement.